155 related articles for article (PubMed ID: 37025490)
41. Evaluation of LiangXue JieDu Therapy in Combination With Western Medicine for Acute-On-Chronic Liver Failure: A Systematic Review and meta-Analysis.
Shi K; Zhang Q; Hou J; Zhang Y; Bi Y; Wang X
Front Pharmacol; 2022; 13():905215. PubMed ID: 35903334
[No Abstract] [Full Text] [Related]
42. Fibrates for the treatment of pruritus in primary biliary cholangitis: a systematic review and meta-analysis.
Shen N; Pan J; Miao H; Zhang H; Xing L; Yu X
Ann Palliat Med; 2021 Jul; 10(7):7697-7705. PubMed ID: 34353058
[TBL] [Abstract][Full Text] [Related]
43. Traditional Chinese Medicine Injections Combined With Antihypertensive Drugs for Hypertensive Nephropathy: A Network Meta-Analysis.
Chen Z; Peng Y; Yang F; Qiang X; Chen Y; Chen Y; Cao L; Liu C; Zhang J
Front Pharmacol; 2021; 12():740821. PubMed ID: 34744724
[No Abstract] [Full Text] [Related]
44. [Meta-analysis of ursodeoxycholic acid and S-adenosylmethionine for improving the outcomes of intrahepatic cholestasis of pregnancy].
Zhou F; Gao B; Wang X; Li J
Zhonghua Gan Zang Bing Za Zhi; 2014 Apr; 22(4):299-304. PubMed ID: 25173231
[TBL] [Abstract][Full Text] [Related]
45. Transcutaneous Neuromodulation improved inflammation and sympathovagal ratio in patients with primary biliary ssscholangitis and inadequate response to Ursodeoxycholic acid: a pilot study.
Yang H; Yang H; Wang L; Shi H; Liu B; Lin X; Chang Q; Chen JDZ; Duan Z
BMC Complement Med Ther; 2020 Aug; 20(1):242. PubMed ID: 32738911
[TBL] [Abstract][Full Text] [Related]
46. Clinical application of oral Chinese Patent Medicines in ophthalmology: a scoping review protocol.
Xu K; Liao X; Liang L; Li Y; Huang Z; Li X; Zhou W; Zuo Q
BMJ Open; 2022 Jun; 12(6):e059571. PubMed ID: 35725246
[TBL] [Abstract][Full Text] [Related]
47. Decreased infiltration of CD4
Yu K; Li P; Xu T; Xu J; Wang K; Chai J; Zhao D; Liu Y; Wang Y; Ma J; Fan L; Guo S; Li Z; Li M; Wang Z
Pathol Res Pract; 2021 Jan; 217():153291. PubMed ID: 33249399
[TBL] [Abstract][Full Text] [Related]
48. Traditional Chinese patent medicine for bile reflux gastritis: a systematic review and network meta-analysis.
He M; Wang Q; Liu L; Bai G
Ann Palliat Med; 2021 Jul; 10(7):7721-7735. PubMed ID: 34353060
[TBL] [Abstract][Full Text] [Related]
49. Therapeutic effects and safety of oral Chinese patent medicine for COVID-19: A rapid systematic review and meta-analysis of randomized controlled trials.
Liang SB; Fang M; Liang CH; Lan HD; Shen C; Yan LJ; Hu XY; Han M; Robinson N; Liu JP
Complement Ther Med; 2021 Aug; 60():102744. PubMed ID: 34091029
[TBL] [Abstract][Full Text] [Related]
50. [Network Meta-analysis of oral blood-activating and stasis-removing Chinese patent medicines in treatment of hypertensive left ventricular hypertrophy].
Zheng YW; Li J; Yao WQ; Pan MY; Fang Y
Zhongguo Zhong Yao Za Zhi; 2022 Mar; 47(5):1383-1391. PubMed ID: 35343167
[TBL] [Abstract][Full Text] [Related]
51. Efficacy and safety of oral traditional Chinese patent medicine in treatment of liver stagnation and spleen deficiency of depression: A protocol for systematic review.
Yu Y; Zhang G; Han T; Huang H
Medicine (Baltimore); 2020 Feb; 99(7):e19142. PubMed ID: 32049837
[TBL] [Abstract][Full Text] [Related]
52. Predictors for incomplete response to ursodeoxycholic acid in primary biliary cholangitis. Data from a national registry of liver disease.
Cortez-Pinto H; Liberal R; Lopes S; Machado MV; Carvalho J; Dias T; Santos A; Agostinho C; Figueiredo P; Loureiro R; Martins A; Alexandrino G; Cotrim I; Leal C; Presa J; Mesquita M; Nunes J; Gouveia C; Vale AHE; Alves AL; Coelho M; Maia L; Pedroto I; Banhudo A; Pinto JS; Gomes MV; Oliveira J; Andreozzi V; Calinas F
United European Gastroenterol J; 2021 Jul; 9(6):699-706. PubMed ID: 34102008
[TBL] [Abstract][Full Text] [Related]
53. Compound
Li K; Cheng H; Shen W; Leung EL; Le S; Yu L; Xie H; Sui X; Zhu X; Wu Q
Evid Based Complement Alternat Med; 2021; 2021():9535061. PubMed ID: 34956388
[TBL] [Abstract][Full Text] [Related]
54. Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis.
Corpechot C; Chazouillères O; Belnou P; Montano-Loza AJ; Mason A; Ebadi M; Eurich D; Chopra S; Jacob D; Schramm C; Sterneck M; Bruns T; Reuken P; Rauchfuss F; Roccarina D; Thorburn D; Gerussi A; Trivedi P; Hirschfield G; McDowell P; Nevens F; Boillot O; Bosch A; Giostra E; Conti F; Poupon R; Parés A; Reig A; Donato MF; Malinverno F; Floreani A; Russo FP; Cazzagon N; Verhelst X; Goet J; Harms M; van Buuren H; Hansen B; Carrat F; Dumortier J;
J Hepatol; 2020 Sep; 73(3):559-565. PubMed ID: 32275981
[TBL] [Abstract][Full Text] [Related]
55. The effectiveness and safety of Chinese medicines for the treatment of uveitis: A protocol for systematic review and meta-analysis.
Han M; Chen Y; Nong L; Liu Z; Qin Y; Meng H; Chen Y; Wang Z; Jin M
Medicine (Baltimore); 2020 Jun; 99(26):e20766. PubMed ID: 32590753
[TBL] [Abstract][Full Text] [Related]
56. [Systematic review and meta-analysis of randomized controlled trials of integrative medicine therapy for treatment of chronic severe hepatitis].
Liu HM; Wang XB; Chang YJ; Gu LL
Zhong Xi Yi Jie He Xue Bao; 2012 Nov; 10(11):1211-28. PubMed ID: 23158939
[TBL] [Abstract][Full Text] [Related]
57. Efficacy and safety of Shenqi Fuzheng injection combined with platinum-based chemotherapy for stage III/IV non-small cell lung cancer: A protocol for systematic review and meta-analysis of randomized controlled trials.
Chen H; Yao X; Liu Z; Li T; Xu C; Wang J; Sui X; Leung EL; Wu Q
Medicine (Baltimore); 2019 Sep; 98(39):e17350. PubMed ID: 31574877
[TBL] [Abstract][Full Text] [Related]
58. Xuesaitong oral preparation as adjuvant therapy for treating acute cerebral infarction: A systematic review and meta-analysis of randomized controlled trials.
Geng H; Zhang L; Xin C; Zhang C; Xie Y
J Ethnopharmacol; 2022 Mar; 285():114849. PubMed ID: 34800648
[TBL] [Abstract][Full Text] [Related]
59. Efficacy and Safety of Oral Chinese Patent Medicine Combined with Conventional Therapy for Heart Failure: An Overview of Systematic Reviews.
Lin SS; Liu CX; Zhang JH; Wang XL; Mao JY
Evid Based Complement Alternat Med; 2020; 2020():8620186. PubMed ID: 32908572
[TBL] [Abstract][Full Text] [Related]
60. Treatment of primary biliary cirrhosis with ursodeoxycholic acid combined with traditional Chinese medicine: A protocol for systematic review and meta analysis.
Chen X; Ma X; Wang R; Wang L; Li J; Liu H; He T; Wei S; Li H; Wang M; Zhao Y
Medicine (Baltimore); 2020 Nov; 99(46):e23107. PubMed ID: 33181677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
